Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
VMF
DRUG PRODUCT COMPOSITIONS
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]INTERMEDIATE SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Canada
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Australia
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
DATA COMPILATION #PharmaFlow
NEWS #PharmaBuzz
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
66
PharmaCompass offers a list of Pemetrexed API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Pemetrexed manufacturer or Pemetrexed supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Pemetrexed manufacturer or Pemetrexed supplier.
PharmaCompass also assists you with knowing the Pemetrexed API Price utilized in the formulation of products. Pemetrexed API Price is not always fixed or binding as the Pemetrexed Price is obtained through a variety of data sources. The Pemetrexed Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A CID125891 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of CID125891, including repackagers and relabelers. The FDA regulates CID125891 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. CID125891 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of CID125891 manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A CID125891 supplier is an individual or a company that provides CID125891 active pharmaceutical ingredient (API) or CID125891 finished formulations upon request. The CID125891 suppliers may include CID125891 API manufacturers, exporters, distributors and traders.
click here to find a list of CID125891 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A CID125891 DMF (Drug Master File) is a document detailing the whole manufacturing process of CID125891 active pharmaceutical ingredient (API) in detail. Different forms of CID125891 DMFs exist exist since differing nations have different regulations, such as CID125891 USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A CID125891 DMF submitted to regulatory agencies in the US is known as a USDMF. CID125891 USDMF includes data on CID125891's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The CID125891 USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of CID125891 suppliers with USDMF on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing CID125891 as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for CID125891 API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture CID125891 as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain CID125891 and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a CID125891 NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of CID125891 suppliers with NDC on PharmaCompass.
CID125891 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of CID125891 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right CID125891 GMP manufacturer or CID125891 GMP API supplier for your needs.
A CID125891 CoA (Certificate of Analysis) is a formal document that attests to CID125891's compliance with CID125891 specifications and serves as a tool for batch-level quality control.
CID125891 CoA mostly includes findings from lab analyses of a specific batch. For each CID125891 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
CID125891 may be tested according to a variety of international standards, such as European Pharmacopoeia (CID125891 EP), CID125891 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (CID125891 USP).
